Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

Management of white cataract using femtosecond laser-assisted cataract surgery (FLACS)

Search Title by author or title

Session Details

Session Title: Femtolaser-Assisted Cataract Surgery (FLACS) II

Session Date/Time: Monday 09/10/2017 | 08:30-10:30

Paper Time: 08:36

Venue: Room 4.4

First Author: : S.Chee SINGAPORE

Co Author(s): :    Y. Yang                    

Abstract Details

Purpose:

To report the outcome of a series of white cataracts managed with the aid of the femtosecond laser.

Setting:

Singapore National Eye Centre

Methods:

Retrospective review of consecutive white cataracts that underwent femtosecond laser assisted cataract surgery (FLACS) using Victus™ (Bausch+Lomb, Munich, Germany) at the Singapore National Eye Centre from June 2012 to Dec 2016. Data collected: patient demographics, type of white cataract, completeness of capsulotomy, best corrected visual acuity (BCVA) at 1 month and intraoperative complications. Outcome measures: capsulotomy completeness and integrity, fragmentation capability and BCVA at 1 month.

Results:

53 eyes of 50 patients underwent FLACS. Type of white cataracts were non-intumescent white (23 eyes), intumescent (25 eyes) and Morgagnian (5 eyes) cataracts. The capsulotomy was incomplete in 8 eyes (15.1%): 1/23 non-intumescent white cataracts, 3/25 intumescent cataracts and 4/5 Morgagnian cataracts. Nucleus fragmentation attempted in 38 eyes was effective in 9 eyes (23.7%) and partially effective in 14 eyes (44.7%). No anterior nor posterior capsule tears occurred. LogMAR visual acuity at 1 month was 0.07 (SD 0.09). The type of white cataract was the only risk factor identified for incomplete capsulotomy (Pearson Chi-Square 18.7, P<0.001).

Conclusions:

Whilst the femtosecond laser enables the surgeon to safely create a capsulotomy in a white cataract, it is incomplete in 15.1%. The type of white cataract was identified as the main risk factor for capsulotomy incompleteness.

Financial Disclosure:

travel has been funded, fully or partially, by a competing company

Back to previous